in ,

Startups pause at-home tests after new FDA guidance

Everlywell, Nurx, and a bevy of other companies had begun marketing at-home tests as the U.S. still faces a shortage. But they had to stop after the Food and Drug Administration clarified that it had not approved at-home testing.

This post was created with our nice and easy submission form. Create your post!

What do you think?


Leave a Reply

Your email address will not be published. Required fields are marked *



Coronavirus Vaccine Identified by Supercomputer